Japan

The cautious nature of Japan's regulatory regime has been demonstrated once again. A government panel has recommended approval of thalidomide for multiple myeloma ten years after... 2008-08-28

Germany's drug discount contracts - which enforce pharmacists to dispense drugs for which health insurers have arranged price reductions with pharmaceutical companies - appear to... 2008-07-21

Merck & Co has launched its integrase inhibitor for HIV Isentress (raltegravir) in Japan through its local subsidiary Banyu.

Following the launch of its breakthrough rheumatoid arthritis therapeutic, US drugmaker Abbott Laboratories is looking to outperform the Japanese patented drug sector over the next... 2008-06-20

In an effort to diversify and increase its presence in emerging markets, Japanese drugmaker Daiichi Sankyo has purchased a controlling stake in Indian generics firm Ranbaxy Laboratories.... 2008-06-12

Another drugmaker has outlined an aggressive strategy to penetrate Japan's booming generic drug sector, confirming the trend that has emerged over the last six months. US-based Mylan... 2008-03-19

Due to a stagnating domestic market, two Japanese pharmaceutical wholesalers have revealed plans to establish joint ventures in China. Mediceo Paltac intends to provide drug management... 2008-02-22

Japanese firm Takeda is to develop and commercialise up to 13 molecules from US-based Amgen's pipeline for its domestic market. Amgen will receive US$200mn upfront, US$702mn in milestone... 2008-02-05

On the back of relatively strong economic growth in 2007, Japan has increased the amount it will spend on healthcare during 2008. BMI tends to welcomes such rises, but in this instance... 2008-01-16

Japanese drugmaker Astellas has announced that it is to cutback it operations in Germany becoming the latest sector player to disinvest in the country. Germany currently places... 2007-08-06